These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 25523187)
21. Do linear logistic model analyses of volatile biomarkers in exhaled breath of cystic fibrosis patients reliably indicate Pseudomonas aeruginosa infection? Španěl P; Sovová K; Dryahina K; Doušová T; Dřevínek P; Smith D J Breath Res; 2016 Aug; 10(3):036013. PubMed ID: 27532768 [TBL] [Abstract][Full Text] [Related]
22. A Distinct Colon-Derived Breath Metabolome is Associated with Inflammatory Bowel Disease, but not its Complications. Rieder F; Kurada S; Grove D; Cikach F; Lopez R; Patel N; Singh A; Alkhouri N; Shen B; Brzezinski A; Baker M; Fiocchi C; Dweik RA Clin Transl Gastroenterol; 2016 Nov; 7(11):e201. PubMed ID: 27831543 [TBL] [Abstract][Full Text] [Related]
23. Exhaled volatile organic compounds analysis in clinical pediatrics: a systematic review. Sola Martínez RA; Pastor Hernández JM; Yanes Torrado Ó; Cánovas Díaz M; de Diego Puente T; Vinaixa Crevillent M Pediatr Res; 2021 May; 89(6):1352-1363. PubMed ID: 32919397 [TBL] [Abstract][Full Text] [Related]
24. The breathprints in patients with liver disease identify novel breath biomarkers in alcoholic hepatitis. Hanouneh IA; Zein NN; Cikach F; Dababneh L; Grove D; Alkhouri N; Lopez R; Dweik RA Clin Gastroenterol Hepatol; 2014 Mar; 12(3):516-23. PubMed ID: 24036050 [TBL] [Abstract][Full Text] [Related]
25. Clinical significance of the glucose breath test in patients with inflammatory bowel disease. Lee JM; Lee KM; Chung YY; Lee YW; Kim DB; Sung HJ; Chung WC; Paik CN J Gastroenterol Hepatol; 2015 Jun; 30(6):990-4. PubMed ID: 25612007 [TBL] [Abstract][Full Text] [Related]
26. The analysis of volatile organic compounds in exhaled breath and biomarkers in exhaled breath condensate in children - clinical tools or scientific toys? van Mastrigt E; de Jongste JC; Pijnenburg MW Clin Exp Allergy; 2015 Jul; 45(7):1170-88. PubMed ID: 25394891 [TBL] [Abstract][Full Text] [Related]
27. Determination of inflammatory bowel disease activity by breath pentane analysis. Kokoszka J; Nelson RL; Swedler WI; Skosey J; Abcarian H Dis Colon Rectum; 1993 Jun; 36(6):597-601. PubMed ID: 8500379 [TBL] [Abstract][Full Text] [Related]
28. Breath analysis of ammonia, volatile organic compounds and deuterated water vapor in chronic kidney disease and during dialysis. Davies SJ; Španěl P; Smith D Bioanalysis; 2014 Mar; 6(6):843-57. PubMed ID: 24702114 [TBL] [Abstract][Full Text] [Related]
29. Volatile Organic Compounds in Exhaled Breath of Idiopathic Pulmonary Fibrosis for Discrimination from Healthy Subjects. Yamada YI; Yamada G; Otsuka M; Nishikiori H; Ikeda K; Umeda Y; Ohnishi H; Kuronuma K; Chiba H; Baumbach JI; Takahashi H Lung; 2017 Apr; 195(2):247-254. PubMed ID: 28247041 [TBL] [Abstract][Full Text] [Related]
31. Detection of volatile organic compounds in exhaled breath to screen lung cancer: a systematic review. Hua Q; Zhu Y; Liu H Future Oncol; 2018 Jul; 14(16):1647-1662. PubMed ID: 29939068 [TBL] [Abstract][Full Text] [Related]
32. Ligand-Capped Ultrapure Metal Nanoparticle Sensors for the Detection of Cutaneous Leishmaniasis Disease in Exhaled Breath. Welearegay TG; Diouani MF; Österlund L; Ionescu F; Belgacem K; Smadhi H; Khaled S; Kidar A; Cindemir U; Laouini D; Ionescu R ACS Sens; 2018 Dec; 3(12):2532-2540. PubMed ID: 30403135 [TBL] [Abstract][Full Text] [Related]
33. Breath analysis by optical fiber sensor for the determination of exhaled organic compounds with a view to diagnostics. Silva LI; Freitas AC; Rocha-Santos TA; Pereira ME; Duarte AC Talanta; 2011 Feb; 83(5):1586-94. PubMed ID: 21238756 [TBL] [Abstract][Full Text] [Related]
34. The Diagnostic Utility of Volatile Organic Compounds in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. Krishnamoorthy A; Chandrapalan S; Ahmed M; Arasaradnam RP J Crohns Colitis; 2024 Feb; 18(2):320-330. PubMed ID: 37540200 [TBL] [Abstract][Full Text] [Related]
35. Volatile organic compounds in the exhaled breath of young patients with cystic fibrosis. Barker M; Hengst M; Schmid J; Buers HJ; Mittermaier B; Klemp D; Koppmann R Eur Respir J; 2006 May; 27(5):929-36. PubMed ID: 16455833 [TBL] [Abstract][Full Text] [Related]
36. Editorial: volatile organic compounds in breath for monitoring IBD-longitudinal studies are essential. Williams HRT; Orchard TR Aliment Pharmacol Ther; 2017 Aug; 46(3):371-372. PubMed ID: 28677293 [No Abstract] [Full Text] [Related]
37. Volatile organic compounds in breath as markers for irritable bowel syndrome: a metabolomic approach. Baranska A; Mujagic Z; Smolinska A; Dallinga JW; Jonkers DM; Tigchelaar EF; Dekens J; Zhernakova A; Ludwig T; Masclee AA; Wijmenga C; van Schooten FJ Aliment Pharmacol Ther; 2016 Jul; 44(1):45-56. PubMed ID: 27136066 [TBL] [Abstract][Full Text] [Related]
38. Exhaled breath condensate: determination of non-volatile compounds and their potential for clinical diagnosis and monitoring. A review. Kubáň P; Foret F Anal Chim Acta; 2013 Dec; 805():1-18. PubMed ID: 24296139 [TBL] [Abstract][Full Text] [Related]
39. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis. Dallinga JW; Smolinska A; van Schooten FJ Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934 [TBL] [Abstract][Full Text] [Related]
40. Geographical variation in the exhaled volatile organic compounds. Amal H; Leja M; Broza YY; Tisch U; Funka K; Liepniece-Karele I; Skapars R; Xu ZQ; Liu H; Haick H J Breath Res; 2013 Dec; 7(4):047102. PubMed ID: 24184568 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]